HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has issued an aggregate of 58,141 common shares of the Company to Simi Grosman, a director of the Company. The shares were issued at a deemed price of $0.095 per share, for a total value of $5,500, as partial payment for services rendered to the Company in the months of January, February and March 2014 pursuant to a services agreement previously disclosed by the Company on March 8, 2013. The shares were issued at a 5% premium to the closing price of the Company’s shares at the end of each month in which services were provided. The shares issued are subject to a four month hold period which will expire on September 30, 2014.